Open original FDA record ↗Recall record
- FDA identifier
- Z-1215-2013
- Company in FDA record
- Becton Dickinson & Co.
- FDA classification date
- May 3, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Increased levels of false positives in BD Probe Tech Neisseria gonorrhoeae Q Amplified DNA assay kits.
Source facts
- Action
- BD Diagnostic Systems sent an "URGENT PRODUCT RECALL" letter via UPS overnight delivery on February 8, 2013. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to verify that these kits have been consumed, returned or destroyed by completing the enclosed form. The firm will issue a no charge replacement for customers' product. Any product remaining in customers' inventory should be discarded or destroyed per their facility procedures. Complete the attached form regardless if any inventory remains, so that the firm may acknowledge customers' receipt of this notification. It is not necessary to contact BD by telephone to receive replacements. Complete and fax the form to: Attention: Regulatory Compliance, Fax: 410-316-4258 OR E-mail to RegulatoryComplianceFax@BD.com. If further assistance is needed regarding replacements, please contact BD Customer Service Department at 1-800-675-0908.
- Initiated
- 2013-02-08
- Root cause
- Environmental control
- Terminated
- 2013-05-13
- Distribution
- Distributed in the states of CA, FL, GA, NJ, and TX.
- Recall number
- Z-1215-2013
- Recall status
- Terminated
- CDRH record ID
- 116151
- FDA classified
- 2013-05-03
- Recall event number
- 64444